Are Risk-Based MCED Tests the Future of Cancer Screening?
Swathi Kodaikal, MSc
Done early enough, personalized, patient data-driven multi-cancer screening will save lives. But are we there yet?
Newly developed computational tool accurately identifies, characterizes, and differentiates cell types in tumor samples